(NASDAQ: HYPR) Hyperfine's forecast annual revenue growth rate of 29.26% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.26%, and it is also forecast to beat the US market's average forecast revenue growth rate of 16.25%.
Hyperfine's revenue in 2026 is $16,537,000.On average, 5 Wall Street analysts forecast HYPR's revenue for 2026 to be $2,181,421,121, with the lowest HYPR revenue forecast at $2,078,553,912, and the highest HYPR revenue forecast at $2,282,697,600. On average, 4 Wall Street analysts forecast HYPR's revenue for 2027 to be $2,839,453,112, with the lowest HYPR revenue forecast at $2,702,120,086, and the highest HYPR revenue forecast at $2,950,804,215.
In 2028, HYPR is forecast to generate $3,775,120,519 in revenue, with the lowest revenue forecast at $3,627,076,577 and the highest revenue forecast at $3,886,153,476.